Stock screenerAll disclosures →
EDGAR →
MRNA
Conviction 79HealthcareScan · Mon, Aug 10, 2026MRNA$59.82+1.10%
ResistanceSupportVol 14Insider sellCongress buyCongress sell4
Vol MA14 5.2M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price59.82
Change+1.10%
Gap+1.01%
Rel volume1.14×
Avg volume5.08M
Avg $ vol296.08M
SMA 2058.45
SMA 5059.54
SMA 20045.75
Price vs 50+0.47%
Price vs 200+30.74%
MA stackbullish
50/200 cross—
Supertrenddown · 65.63
RSI (14)51
MACD hist0.06
MACD crossbull · 0d
Stoch %K / %D89 / 60
ADX (14)18
+DI / −DI18 / 20
RSI divergence—
MACD divergence—
ATR %+6.62%
ADR %5.57%
52w high81.80
52w low22.36
From 52w high-26.87%
Above 52w low+167.53%
New 52w highNo
SqueezeOff
Bollinger width27.39%
%B0.59
Donchian pos45.23%
Donchian high68.49
Donchian low52.66
AVWAP (52w high)64.69
vs AVWAP high-7.52%
AVWAP (52w low)47.59
vs AVWAP low+25.69%
OBV trendFlat
Chaikin MF (20)-0.16
Today vs 20d1.14×
Avg vol (14d)5.2M
Avg vol (20d)5.08M
Avg $ vol (20d)296.08M
Market cap23.88B
RS 3m (vs SPY)+16.20%
RS 6m (vs SPY)+30.66%
RS line new highNo
Trend template7/8
Technical rank69.2
1 week+8.49%
1 month-12.38%
3 months+10.06%
6 months+45.87%
1 year+124.80%
YTD+93.84%
P/E-8.46
P/B3.53
P/S12.29
P/FCF-11.57
EPS-7.26
Div yield—
ROE-41.74%
ROA-25.75%
Debt/Eq0.09
Current2.29
EV/EBITDA-7.95
Gross margin—
Net margin-145.16%
Rev growth-39.93%
EPS growth20.75%
Price target48.92
Target upside-18.22%
Analyst ratingHold
Institutional90.27%
Ent. value22.75B
Revenue145M
Net income-782M
Gross profit—
Free cash flow-2.06B
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out396.79M
Employees4.7K
ListedFri, Dec 7, 2018
Free float361.08M
Float %91.0%
Short interest52.4M
Days to cover6.1d
Short volume62.0%
Squeeze score71 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.97 vs −$1.97
Last surprise0.0% beat
Setup gradeA
Conviction79 / 100
Pattern quality—
Tech rank69.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance76.67
Support53.00
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MRNA · 3 recent
Insider activity
SEC Form 4 transactions in MRNA · 2 buys · 8 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bancel Stephane Chief Executive Officer · Common Stock · 2026-08-06 | Exercise | 252.47K | $4.8M | 2026-08-06 | 2026-08-07 |
Bancel Stephane Chief Executive Officer · Stock Option (Right to Buy) · 2026-08-06 | Exercise | 187.54K | — | 2026-08-06 | 2026-08-07 |
Bancel Stephane Chief Executive Officer · Stock Option (Right to Buy) · 2026-08-06 | Exercise | 64.93K | — | 2026-08-06 | 2026-08-07 |
Bancel Stephane Chief Executive Officer · Common Stock · 2026-08-05 | Sell | 39.89K | $2.3M | 2026-08-05 | 2026-08-07 |
Bancel Stephane Chief Executive Officer · Common Stock · 2026-08-05 | Sell | 187.04K | $11M | 2026-08-05 | 2026-08-07 |
Bancel Stephane Chief Executive Officer · Stock Option (Right to Buy) · 2026-08-05 | Exercise | 370.85K | — | 2026-08-05 | 2026-08-07 |
Bancel Stephane Chief Executive Officer · Stock Option (Right to Buy) · 2026-08-05 | Exercise | 128.39K | — | 2026-08-05 | 2026-08-07 |
Bancel Stephane Chief Executive Officer · Common Stock · 2026-08-05 | Sell | 147.47K | $8.3M | 2026-08-05 | 2026-08-07 |
Bancel Stephane Chief Executive Officer · Common Stock · 2026-08-05 | Exercise | 499.25K | $9.6M | 2026-08-05 | 2026-08-07 |
Bancel Stephane Chief Executive Officer · Common Stock · 2026-08-05 | Sell | 124.84K | $7.1M | 2026-08-05 | 2026-08-07 |
SEC filings
EDGAR filings in MRNA · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.